Prophylactic surgery for BRCA1 and BRCA2 carriers

Share :
Published: 12 Jan 2009
Views: 18149
Rating:
Save
Dr. William Wood, Chairman of the Department of Surgery, Emory University School of Medicine

Pre-emptive surgey to remove breasts and ovaries to prevent breast cancer in high risk BRCA1 and BRCA2 gene carrying patients; many factors to take into account in making the decision. MRI scans for high risk groups, chemoprevention and oophorectomy to prevent breast cancer.

Related Videos

ERBB2 amplifications across sex, race, and cancer types studied to guide HER2 therapies

Dr Marc Machaalani - Dana-Farber Cancer Institute, Boston, USA
ERBB2 amplifications across sex, race, and cancer types studied to guide HER2 therapies ( Dr Marc Machaalani - Dana-Farber Cancer Institute, Boston, USA )
14 Sep 2024

Genomic testing: Awareness and effective communication between healthcare professionals and patients

Prof Richard Simcock and Antonella Cardone
Genomic testing: Awareness and effective communication between healthcare professionals and patients ( Prof Richard Simcock and Antonella Cardone )
22 Oct 2023

Community-based breast cancer control programme in the Philipines

Kara Magsanoc-Alikpala - ICanServe Foundation, Manila, Philippines
Community-based breast cancer control programme in the Philipines ( Kara Magsanoc-Alikpala  - ICanServe Foundation, Manila, Philippines )
4 Sep 2023

Initiatives for cancer control in Indonesia

Dr K Kardinah - National Cancer Center/Dharmais Cancer Hospital, Jakarta, Indonesia
Initiatives for cancer control in Indonesia ( Dr K Kardinah - National Cancer Center/Dharmais Cancer Hospital, Jakarta, Indonesia )
4 Sep 2023

PHERGain trial ID's early breast cancer cases that benefit from dual HER2 blockade without chemo

Dr Javier Cortes - Vall d’Hebron University Hospital, Barcelona, Spain
PHERGain trial ID's early breast cancer cases that benefit from dual HER2 blockade without chemo ( Dr Javier Cortes - Vall d’Hebron University Hospital, Barcelona, Spain )
5 Jun 2023

Navigating evidence-based care with limited resources in Africa

Dr Verna Vanderpuye - National center for Radiotherapy and Nuclear Medicine, Accra, Ghana
Navigating evidence-based care with limited resources in Africa ( Dr Verna Vanderpuye - National center for Radiotherapy and Nuclear Medicine, Accra, Ghana )
6 Feb 2023

Genetic profiling identifies patients who can omit radiation therapy after breast-conserving surgery

Prof Per Karlsson - Sahlgrenska Comprehensive Cancer Centre, Gothenburg, Sweden
Genetic profiling identifies patients who can omit radiation therapy after breast-conserving surgery ( Prof Per Karlsson - Sahlgrenska Comprehensive Cancer Centre, Gothenburg, Sweden )
21 Dec 2022

Assessment of cervical and breast cancer screening in Latin America and Caribbean: CanScreen5/CELAC project

Dr Isabel Mosquera - International Agency for Research on Cancer, Lyon, France
Assessment of cervical and breast cancer screening in Latin America and Caribbean: CanScreen5/CELAC project ( Dr Isabel Mosquera - International Agency for Research on Cancer, Lyon, France )
21 Nov 2022

Long-term breast cancer risk after benign breast disease in population-based screening

Dr Marta Roman - Hospital del Mar Medical Research Institute, Barcelona, Spain
Long-term breast cancer risk after benign breast disease in population-based screening ( Dr Marta Roman - Hospital del Mar Medical Research Institute, Barcelona, Spain )
18 Nov 2022